Health & Biotech
Dr Anthony Filippis to helm Neurotech as it advances its NTI164 strategy in 2025
NUZ inks positive opinion on orphan product designation for NUZ-001 in Europe
Recce green lit to begin dosing in registrational Phase 3 trial for diabetic foot infections
Scott Power: ACCC’s approval of Sigma, Chemist Warehouse union turned heads this week
Health Check: Neuren’s ‘Willy Wonka’ voucher shows how a piece of paper can be worth US$50m
Health Check: Prestigious publication supports Alterity’s ‘iron overload in brain’ thesis
Spark Plus sees 225pc upside in biotech player Neurizon
October Health Winners: Uscom, Respiri lead sluggish sector, but ‘time in the market, not timing, is key’
ASX imaging stocks target lucrative US veterans health market
Biocurious: Island Pharmaceuticals’ two-pronged plan to put the mozz on dengue fever
Recce Phase II clinical trial reaches key dosing milestone
Health Check: Which biotech boards are at risk of a ‘second strike’?
Optiscan inks deal with Monash Uni to progress GI scope
Dr Boreham’s Crucible: Can this cancer drug developer hit right notes for commercial success?
Health Check: Nuclear medicine stocks tipped to glow after favourable US decision
Cardiex launches CONNEQT Pulse pre-orders with 20,000+ US waitlist
Scott Power: Which company dropped 30pc on its latest quarterly result?
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
